PFKL antibody (Middle Region)
Quick Overview for PFKL antibody (Middle Region) (ABIN629821)
Target
See all PFKL AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Middle Region
-
Specificity
- PFKL antibody was raised against the middle region of PFKL
-
Purification
- Purified
-
Immunogen
- PFKL antibody was raised using the middle region of PFKL corresponding to a region with amino acids RTNVLGHLQQGGAPTPFDRNYGTKLGVKAMLWLSEKLREVYRKGRVFANA
-
-
-
-
Application Notes
-
WB: 2.5 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
PFKL Blocking Peptide, (ABIN5615326), is also available for use as a blocking control in assays to test for specificity of this PFKL antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of PFKL antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- PFKL (Phosphofructokinase, Liver (PFKL))
-
Alternative Name
- PFKL
-
Background
- Phosphofructokinase (PFK) is a tetrameric enzyme that catalyzes a key step in glycolysis, namely the conversion of D-fructose 6-phosphate to D-fructose 1,6-bisphosphate. PFK from muscle is a homotetramer of M subunit, PFK from liver is a homotetramer of L-subunits, while PFK from platelets can be composed of any tetrameric combination of M and L subunits. PFKL represents the L subunit.
-
Molecular Weight
- 64 kDa (MW of target protein)
-
Pathways
- Negative Regulation of Hormone Secretion, Warburg Effect
Target
-